Domingo Liotta and Surgery in 1953. In 1955, he developed a technique for early diagnosis of tumors in the pancreas and ampulla of Vater (Pour le diagnostic des tumeurs du pancreas: La duodenographie hypotonique. Lyon Chirurgical, 1955). Liotta continued his medical career at the University of Lyon (France) at the "Pierre Mallet-Guy's" General Surgery Service. Then, he trained in thoracic and cardiac surgery, with Professors Paul Santy and Pierre Marion in Lyon France. His early works in the artificial heart are from 1958 in Córdoba, Argentina, where he developed an early prototype successfully used in small animals. After publishing the results of
Artificial cell cells have been proposed as a non-viral vector by which genetically modified non-autologous cells are encapsulated and implanted to deliver recombinant proteins "in vivo". This type of immuno-isolation has been proven efficient in mice through delivery of artificial cells containing mouse growth hormone which rescued a growth-retardation in mutant mice. A few strategies have advanced to human clinical trials for the treatment of pancreatic cancer, lateral sclerosis and pain control. The first clinical use of artificial cells was in hemoperfusion by the encapsulation of activated charcoal. Activated charcoal has the capability of adsorbing many large molecules and has for a